Core Points - The Business Wire site is currently unavailable due to scheduled maintenance and will be back shortly [1][4] - Clients wishing to submit news releases are advised to contact their local Business Wire bureau for assistance [3][4] Contact Information - Contact numbers for various countries are provided for clients needing assistance during the downtime, including the US, UK, Germany, France, Japan, and Australia [4][5][6]

Core Insights - Acadia Healthcare has appointed Todd Young as the new chief financial officer in response to increasing pressure from activist investors to enhance performance and governance [1] Company Developments - The appointment of Todd Young is a strategic move by Acadia Healthcare to address the demands of activist investors [1] - The company is facing scrutiny regarding its performance and governance practices, indicating a need for improvement [1]

Core Insights - Activist investors are focusing on Acadia Healthcare (ACHC), which has faced challenges such as federal investigations and operational issues, leading to a decline in stock performance [1][6] - Engine Capital acquired approximately 3% of Acadia, resulting in a nearly 12% increase in stock price on the same day, and has called for significant changes in the company's strategy and board composition [2][3] - Acadia Healthcare is one of the largest behavioral healthcare providers in the U.S., operating over 260 facilities and employing around 25,000 staff [4][5] Company Overview - Acadia Healthcare is valued at approximately $2.5 billion, but its stock has decreased nearly 52% over the past year, contrasting with a 17% gain in the S&P 500 Index [6] - The company operates a diverse range of behavioral healthcare facilities, including inpatient psychiatric hospitals and outpatient clinics, with around 11,800 beds available [4][5] - Recent activist involvement has led to a 10% rebound in stock price over five trading days, indicating a potential shift in market sentiment [6]

Group 1 - Acadia Healthcare Company, Inc. (ACHC) has been added to the Zacks Rank 5 (Strong Sell) List due to a 4.9% downward revision in the consensus estimate for its current year earnings over the last 60 days [1] - Allison Transmission Holdings, Inc. (ALSN) is also on the Zacks Rank 5 (Strong Sell) List, with a 5.5% downward revision in the consensus estimate for its current year earnings over the last 60 days [2] - Black Stone Minerals, L.P. (BSM) has seen a 10.5% downward revision in the consensus estimate for its current year earnings over the last 60 days, leading to its inclusion in the Zacks Rank 5 (Strong Sell) List [2]

Core Insights - Acadia Healthcare is a leading provider in the behavioral healthcare sector, offering a range of services including psychiatric and addiction treatment [1] - The company is facing challenges related to governance and performance, as highlighted by a major shareholder's call for a strategic review [3] Stock Performance - On October 3, 2025, Raymond James upgraded Acadia Healthcare to "Outperform" with a new price target of $30, up from $26, indicating a positive outlook for the stock [2][5] - ACHC's stock price increased by 8.43%, or $2.07, reflecting strong investor interest, with a trading range of $24.57 to $26.72 for the day [4][5] - Over the past year, ACHC has experienced significant volatility, with a high of $60.52 and a low of $17.13 [4] Market Position - Acadia Healthcare's market capitalization is approximately $2.46 billion, indicating its substantial presence in the market [4] - The trading volume for ACHC today was 3,511,931 shares on the NASDAQ exchange, demonstrating active investor engagement [4]

Core Viewpoint - Khrom Capital Management, a major shareholder of Acadia Healthcare, is urging the company's board to initiate a formal strategic review, which may include a potential sale, due to years of underperformance [1] Group 1 - Khrom Capital Management is one of the largest shareholders of Acadia Healthcare [1] - The call for a strategic review is based on the company's prolonged poor performance [1] - The potential sale is part of the strategic options being considered [1]

Core Insights - Acadia Healthcare is one of the largest operators of behavioral health facilities in the U.S. [1] - The company is participating in the 2025 Jefferies Healthcare Services Conference, indicating its active engagement with investors and stakeholders [1] Company Announcements - Acadia Healthcare issued an 8-K filing, which includes important announcements regarding recent activism directed at the company [2] - The CEO of Acadia Healthcare, Hunter, is addressing the activism and related announcements during the conference [2]

Acadia Healthcare Company Conference Call Summary Company Overview - Acadia Healthcare Company is one of the largest operators of behavioral health facilities in the U.S. [1] Core Industry Insights - The demand for behavioral health services remains structurally strong, particularly for patients with rising acuity and comorbidities [17] - There is a supply-demand imbalance in behavioral health, especially in underserved areas [17] - The company is focused on delivering high-quality, evidence-based behavioral health services [2] Financial Performance and Guidance - 2025 has been a challenging year for Acadia, with volumes coming in below expectations due to weaker Medicaid volumes [2][3] - The company has paused several projects, reducing 2026 CapEx by at least $300 million compared to 2025 levels [4][12] - Acadia added nearly 1,800 beds between 2024 and 2025 and expects to add an additional 500 to 700 beds in 2026 [4][7] - The company anticipates significant improvement in EBITDA growth and free cash flow generation in 2026 and 2027 [7][8] Operational Strategy - Acadia is taking a more measured approach to capital deployment, focusing on markets with favorable reimbursement environments [13][18] - The company has closed five underperforming facilities to concentrate resources on core business areas [23] - A comprehensive review of facilities is ongoing, with five additional facilities being monitored for potential closure [26] Medicaid Dynamics - Challenges in the acute line of business include payer behavior, leading to denials and reduced lengths of stay for patients [9][10] - The company is experiencing tighter scrutiny from managed Medicaid plans [10] Capital Expenditure and Investment - The decision to cut CapEx was driven by a thorough review of growth opportunities and market demand [11][12] - Acadia is focusing on optimizing capital deployment and enhancing shareholder value through strategic facility closures [22][28] Quality and Technology Investments - Acadia has made significant investments in technology and quality infrastructure, which are expected to improve clinical outcomes and operational consistency [20][47] - The company tracks over 50 key performance indicators (KPIs) to ensure quality and operational efficiency [47] Market Position and Competitive Landscape - Acadia differentiates itself through technology and quality, addressing the historical underinvestment in behavioral health [20] - The company is well-positioned to leverage its joint venture partnerships for reimbursement advantages [41] Future Outlook - Acadia expects to unlock free cash flow potential and achieve strong top and bottom line growth in the coming years [48] - The company is closely monitoring the evolving reimbursement environment, particularly with upcoming changes in state-directed payments [44][46] Key Takeaways - The depth of Acadia's quality infrastructure and operational discipline is often underappreciated by investors [47] - The company is committed to sustainable growth and long-term expansion despite current challenges [48]

Core Insights - Acadia Healthcare Company, Inc. (ACHC) shares increased by 11.7% following Engine Capital's announcement of a 3% stake and a call for significant changes within the company [1][6] - Engine Capital believes Acadia is undervalued due to strong cash generation and real estate, which have been overshadowed by poor execution and management issues [2][3] - ACHC's current forward P/E ratio is 8.87X, significantly lower than its five-year median of 20.55X and the industry average of 13.55X, indicating potential for operational improvements to unlock value [3][4] Company Performance - ACHC's stock has declined by 67.5% over the past year, compared to a 5.8% decline in the industry, exacerbated by a Department of Justice investigation into alleged misconduct [4][6] - The Zacks Consensus Estimate for ACHC's 2025 earnings is $2.54 per share, reflecting a 23% decrease year-over-year [11] Proposed Changes by Engine Capital - Engine Capital is advocating for a board refresh with directors experienced in behavioral health and capital allocation, realigning executive compensation, and pausing aggressive expansion [7] - The proposal includes streamlining operations, reinstating a regional leadership model, and monetizing select assets to fund buybacks, aimed at restoring investor trust and closing the valuation gap [7] Industry Context - Competitors like Tenet Healthcare Corporation (THC) and HCA Healthcare, Inc. (HCA) are experiencing growth due to rising demand from an aging population and increased disease cases [9][10] - THC is benefiting from higher patient revenue and strategic divestitures, while HCA is leveraging increased admissions and a broad healthcare services network [10]

Core Viewpoint - Activist investor Engine Capital is urging Acadia Healthcare to restructure its board and reassess its growth strategy due to ongoing federal investigations and significant share price declines [1][2]. Group 1: Investor Pressure - Engine Capital holds approximately a 3% stake in Acadia, making it one of the company's ten largest shareholders [1]. - The hedge fund has called for a halt to costly new projects and a review of the asset portfolio [2][3]. - The letter highlights Acadia's consistent negative returns and underperformance compared to healthcare peers, resulting in shares being undervalued [2][5]. Group 2: Operational Concerns - Underperformance is attributed to poor execution, missteps in reorganization under CEO Christopher Hunter, rising costs, and inadequate board oversight [3][4]. - Engine Capital criticizes Acadia's "growth at any cost" strategy, which has led to an oversized corporate structure and limited operational improvements [4]. - The hedge fund emphasizes the need for a board refresh with directors who have experience in behavioral health and capital allocation [4][5]. Group 3: Financial Performance - Acadia's market value has significantly decreased, with shares down 71% over the past year, placing its equity valuation just above $2 billion [5]. - The stock price has recently seen a slight increase of 9.87%, reaching $24.19 [5].